View All Key Stats
VSTM Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.75 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -67.80M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 209.22M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | -- |
| PE Ratio (TTM) | -- |
| Price to Book Value | 3.627 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -20.33M |
| Return on Equity (TTM) | Upgrade |
View All VSTM News
VSTM News
-
WireHeadlineTime (ET)
-
Business Wire04/23 07:00
-
Globe Newswire04/19 08:00
-
Yahoo04/13 08:37
-
SA Breaking News04/09 17:36
-
Business Wire04/09 16:05
-
MT Newswires04/09 12:57
-
Yahoo04/09 11:10
-
SA Breaking News04/09 09:11
-
Yahoo04/09 08:44
-
MT Newswires04/09 08:25
View All Events
VSTM Events
| Date | Type | Description |
|---|---|---|
| 03/23/2018 | Misc | Verastem Inc Fourth Quarter Earnings Conference Call in 2018 |
| 03/23/2018 | Earnings | Verastem Inc Fourth Quarter Earnings Results in 2018 |
| 11/07/2017 | Earnings | Verastem Inc Third Quarter Earnings Results in 2017 |
| 08/08/2017 | Earnings | Verastem Inc Second Quarter Earnings Results in 2017 |
| 05/17/2017 | Misc | Verastem Inc Annual General Meeting in 2016 |
| 05/10/2017 | Earnings | Verastem Inc First Quarter Earnings Results in 2017 |
VSTM Fundamentals
Income Statement View Statement
VSTM Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
VSTM One Page Reports
- One Page Report Download
VSTM Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 4.11 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.verastem.com
- Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=250749&p=irol-irhome
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: N/A
- Last Earnings Release: Mar. 23, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Verastem Inc is a biopharmaceutical company engaged in discovering and developing drugs to improve outcomes for patients with cancer. Its product candidates include duvelisib and defactinib.
VSTM Excel Add-In Codes
- Name: =YCI("VSTM","name")
- Description: =YCI("VSTM","description")
- Sector: =YCI("VSTM","sector")
- Industry: =YCI("VSTM","industry")
- Est. Current Fiscal Year End: =YCI("VSTM","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other VSTM Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- VSTM Tweets Stocktwits
Advertisement
